DYN
Dyne Therapeutics Inc

2,672
Mkt Cap
$2.71B
Volume
2.08M
52W High
$25.00
52W Low
$6.36
PE Ratio
-4.53
DYN Fundamentals
Price
$16.58
Prev Close
$16.71
Open
$16.52
50D MA
$19.37
Beta
1.81
Avg. Volume
3.12M
EPS (Annual)
-$3.37
P/B
3.42
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
JPMorgan Chase & Co. Lowers Dyne Therapeutics (NASDAQ:DYN) Price Target to $16.00
JPMorgan Chase & Co. cut their price target on shares of Dyne Therapeutics from $17.00 to $16.00 and set a "neutral" rating for the company in a research report on Tuesday...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Campbell & CO Investment Adviser LLC Purchases Shares of 64,517 Dyne Therapeutics, Inc. $DYN
Campbell & CO Investment Adviser LLC bought a new stake in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·18h ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Trading Down 4.9% - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Trading Down 4.9% - What's Next...
MarketBeat·5d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6% - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Trading Down 6% - Here's What Happened...
MarketBeat·12d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Shares Down 6.7% - What's Next?
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6.7% - Time to Sell...
MarketBeat·18d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Dyne Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·24d ago
News Placeholder
Dyne Therapeutics, Inc. $DYN Shares Purchased by Squarepoint Ops LLC
Squarepoint Ops LLC raised its position in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 334.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned...
MarketBeat·1mo ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen raised shares of Dyne Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Rating of "Moderate Buy" by Analysts
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nineteen analysts that are covering the company, Marketbeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
TFG Asset Management GP Ltd Acquires New Stake in Dyne Therapeutics, Inc. $DYN
TFG Asset Management GP Ltd bought a new position in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1mo ago
<
1
2
...
>

Latest DYN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.